What is Solara Active Pharma Sciences Ltd. Quarterly Revenue?

Solara Active Pharma Sciences Ltd. Quarterly Revenue Solara Active Pharma Jun-2026 Quarterly Revenue is Rs 384 Cr which is growth of 19.8% YoY.

What is Solara Active Pharma Sciences Ltd. Quarterly Net Profit?

Solara Active Pharma Sciences Ltd. Quarterly Net Profit Solara Active Pharma Jun-2026 Quarterly Net Profit is Rs 17 Cr which is growth of 61.3% YoY.

What is Solara Active Pharma Sciences Ltd. Annual Revenue?

Solara Active Pharma Sciences Ltd. Annual Revenue Solara Active Pharma Mar-2026 Annual Revenue is Rs 1,375 Cr which is growth of 6.3% YoY.

What is Solara Active Pharma Sciences Ltd. Annual Net Profit?

Solara Active Pharma Sciences Ltd. Annual Net Profit Solara Active Pharma Mar-2026 Annual Net Profit is Rs -7 Cr which is growth of -570.4% YoY.

What is Solara Active Pharma Sciences Ltd. Total Shareholders Fund?

Solara Active Pharma Sciences Ltd. Total Shareholders Fund Solara Active Pharma Mar-2026 Total Shareholders Fund is Rs 1,255 Cr which is growth of 14.5% YoY.

What is Solara Active Pharma Sciences Ltd. Total Assets?

Solara Active Pharma Sciences Ltd. Total Assets Solara Active Pharma Mar-2026 Total Assets is Rs 2,277 Cr which is growth of 2.3% YoY.

What is Solara Active Pharma Sciences Ltd. Book Value Per Share?

Solara Active Pharma Sciences Ltd. Book Value Per Share Solara Active Pharma Mar-2026 Book Value Per Share is 282 Rs which is growth of 3.6% YoY.

What is Solara Active Pharma Sciences Ltd. ROE?

Solara Active Pharma Sciences Ltd. ROE Solara Active Pharma Mar-2026 ROE is -1% which is growth of 0.5% YoY.

What is Solara Active Pharma Sciences Ltd. Cash From Operating Activity?

Solara Active Pharma Sciences Ltd. Cash From Operating Activity Solara Active Pharma Mar-2026 Cash From Operating Activity is Rs 153 Cr which is growth of -28.2% YoY.

What is Solara Active Pharma Sciences Ltd. Net Cash Flow?

Solara Active Pharma Sciences Ltd. Net Cash Flow Solara Active Pharma Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of 104.2% YoY.

Solara Active Pharma Sciences Ltd.

NSE: SOLARA | BSE: 541540

Expensive Rocket

Download real time

-10.55(-1.45%)

69.40% Gain from 52W Low

261.8K

NSE+BSE Volume

NSE 01 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Solara Active Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Solara Active Pharma share price target, revenues, EPS, net income and more

Solara Active Pharma quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Solara Active Pharma Jun-2026 Quarterly Revenue is Rs 384 Cr which is growth of 19.8% YoY.
POSITIVE
Quarterly Net Profit Solara Active Pharma Jun-2026 Quarterly Net Profit is Rs 17 Cr which is growth of 61.3% YoY.

Solara Active Pharma Sciences Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	383.5	391.7	349	314	320.1	279	301.8	347.3	364.9	301.1	249.2	426.5	354.4
SR_Q Operating Rev.	381.6	387.3	349	313.5	319.2	273	300.3	347	363.5	299.4	248.7	425.2	352.3
OI_Q Other Income	1.9	4.4		0.5	1	6	1.5	0.3	1.4	1.6	0.4	1.2	2.1
OEXPNS_Q Operating Exp.	319.6	329.7	311.7	278.8	262.1	230.4	242.6	285.6	321.3	289.6	410.4	387.6	333.2
OEXPNS_Q Operating Exp.	319.6	329.7	311.7	278.8	262.1	230.4	242.6	285.6	321.3	289.6	410.4	387.6	333.2
OP_Q Operating Profit	62	57.6	37.4	34.8	57	42.6	57.7	61.3	42.2	9.8	-161.7	37.7	19.1
OPMPCT_Q Operating Profit Margin %	16.25%	14.86%	10.70%	11.08%	17.87%	15.60%	19.21%	17.67%	11.62%	3.27%	-65.00%	8.86%	5.43%
DEP_Q Depr.	26.7	26	25.6	24.5	23.6	24.3	24.5	25.3	25.1	25.1	26	26.1	25.8
INT_Q Interest	20.2	27.1	22.5	20.8	23.9	29.1	26.5	28.3	30.9	30.6	25.4	24.5	25.5
PBT_Q Profit Before Tax	17	9.7	-17.4	-10.1	10.5	-4.9	8.1	8	-12.3	-167.6	-275.3	-15.3	-30.1
TAX_Q Tax										88.8			-10.3
NP_Q Net Profit	17	9.7	-17.4	-10.1	10.5	-4.9	8.1	8	-12.3	-256.4	-275.3	-15.3	-19.9
EPS_adj_Q EPS Adj. latest	3.5	2	-3.6	-2.1	2.2	-1	1.7	1.7	-2.6	-53.4	-57.3	-3.2	-4.1
NP_TTM Net profit TTM	-0.8	-7.2	-21.9	3.7	21.8	-1.1	-252.6	-536	-559.3	-566.9	-304	-28.3	-22.9
EPS_TTM Basic EPS TTM	-0.2	-1.6	-4.9	0.8	4.9	-0.3	-62.8	-133.3	-139.1	-157.5	-84.5	-7.9	-6.4
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes		Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Solara Active Pharma competitor comparison and performance snapshot within industry

Solara Active Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Solara Active Pharma Mar-2026 Annual Revenue is Rs 1,375 Cr which is growth of 6.3% YoY.
NEGATIVE
Annual Net Profit Solara Active Pharma Mar-2026 Annual Net Profit is Rs -7 Cr which is growth of -570.4% YoY.

Solara Active Pharma Sciences Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18
SR_A Total Rev. Ann. ⌄	-2.1%	-3.5%	1,438.3	1,374.9	1,292.9	1,294.3	1,466	1,287.1	1,645.3	1,349.3	1,374.1	523.3
TotalOperatingRevenues_A Operating Rev. Ann.	-1.8%	-3.3%	1,431.4	1,369	1,283.8	1,288.9	1,443.8	1,268.3	1,616.9	1,321.8	1,367.3	521
OI_A Other Income Ann.	-35.6%	-27%	6.8	5.9	9.1	5.4	22.1	18.8	28.4	27.5	6.8	2.3
OEXPNS_A Operating Exp. Ann.	-3.4%	-0.8%	1,239.8	1,182.3	1,079.9	1,384	1,309.8	1,188	1,231.6	1,065.2	1,141.2	456.7
OEXPNS_A Operating Exp. Ann.	-3.4%	-0.8%	1,239.8	1,182.3	1,079.9	1,384	1,309.8	1,188	1,231.6	1,065.2	1,141.2	456.7
OP_A Operating Profit Ann.	11.7%	-13.5%	191.7	186.7	203.8	-95.1	134	80.4	385.3	256.5	226.1	64.3
OPMPCT_A OPM Ann. %	14.1%	-10.3%		13.58%	15.77%	-7.34%	9.14%	6.24%	23.42%	19.01%	16.45%	12.28%
TotalExpenses_A Total Exp. Ann. ⌄	-3.1%	-0.7%		1,376.2	1,294	1,593	1,510.7	1,375.3	1,424.3	1,236.8	1,302.3	515.7
OtherExpenses_A Other Exp. Ann.	-1.7%	-0.1%	283.7	278.6	241.8	335	292.9	299.9	279.5	264.1	262.4	117.4
EmployeeBenefitExpenses_A Employee Exp. Ann.	-1.3%	-0.7%	221.6	219.2	211.7	243.9	228.1	234.2	227.6	202.2	179.9	67.6
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	7.2%	-14.2%		192.6	213	-89.7	156.2	99.1	413.7	284	232.9	66.5
EBIDTPCT_A EBITDA Ann. margin %	9.6%	-11%		14.01%	16.47%	-6.93%	10.65%	7.70%	25.15%	21.05%	16.95%	12.72%
INT_A Interest Ann.	1.5%	2.2%	90.6	94.2	114.8	106	90.1	75.3	84.5	77.9	82.4	25.1
DEP_A Depr.	-3.5%	-1.6%	102.8	99.7	99.3	103	110.9	112	108.3	93.7	78.7	33.8
PBT_A PBT Ann.	-	-	-0.8	-7.2	-1.1	-488.3	-44.8	-91.7	221	112.5	71.7	7.6
TAX_A Tax Ann.	-	-				78.5	-22.6	-33.1			2
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-	-		-7.2	-1.1	-566.9	-22.2	-58.6	221	112.5	69.7	7.6
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-	-	-0.8	-7.2	-1.1	-566.9	-22.2	-58.6	221	112.5	62	2
NETPCT_A NPM Ann. %	-	-		-0.52%	-0.08%	-43.98%	-1.53%	-4.61%	13.66%	8.51%	4.53%	0.37%
EPS_adj_A EPS Adj. latest Ann.	-	-		-1.5	-0.2	-118	-4.6	-12.2	46	23.4	12.9	0.4
result_notes Result Notes				Notes			Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

6.3%

2Y CAGR

3.1%

3Y CAGR

-2.1%

5Y CAGR

-3.5%

7Y CAGR

Total Revenue Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

9.5%

2Y CAGR

-7.6%

3Y CAGR

-3.4%

5Y CAGR

-0.8%

7Y CAGR

0.5%

Operating Expenses Annual Cr growth is higher than historical averages.

Solara Active Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Solara Active Pharma Mar-2026 Total Shareholders Fund is Rs 1,255 Cr which is growth of 14.5% YoY.
POSITIVE
Total Assets Solara Active Pharma Mar-2026 Total Assets is Rs 2,277 Cr which is growth of 2.3% YoY.

Solara Active Pharma Sciences Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-5.8%	-4.6%	1,255.4	1,096.2	937.4	1,503.1	1,527.1	1,592.8	994.8	861.7	769.9
EQCAP_A Equity Share Capital Ann.	7.3%	4.4%	44.5	40.3	36	36	36	35.9	26.9	25.8	24.7
TotalShareCapital_A Total Share Capital Ann.	7.3%	4.4%	44.5	40.3	36	36	36	35.9	26.9	25.8	24.7
ReservesAndSurplus_A Reserves Plus Surplus Ann.	-6.2%	-4.9%	1,210.9	1,056	899.8	1,466.1	1,491.1	1,556.9	967.9	836	745.2
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	-6.2%	-4.9%	1,210.9	1,056	899.8	1,466.1	1,491.1	1,556.9	967.9	836	745.2
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-23.3%	-10.5%	133.6	190.8	171.5	295.7	354.4	232.1	333.1	343.5	314.9
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-							11.8	32.8	48.4
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-27.3%	-21.9%	19.2	67.1	55.6	49.9	61.8	65.9	78	77	16.3
CL_A Total Current Liabilities Ann. ⌄	-6.8%	2.5%	887.5	938.1	1,237.7	1,096.1	1,068.3	785.3	727.7	625.6	732.4
TradePayables_A Trade Payables Ann.	-3.8%	-2.6%	267.6	242.6	307.7	300.7	280.8	305.6	215.7	224.5	312.6
OtherCurrentLiabilities_A Other Current Liabilities Ann.	24%	-15%	52	31.1	34.4	27.3	42.5	117	156.4	185.2	88.4
ShortTermProvisions_A ST Provisions Ann.	87.8%	50.5%	13.9	2.2	2	2.1	3.4	1.8	1.9	1.5	1.3
TL_A Total Capital Plus Liabilities Ann.	-7.7%	-2.7%	2,276.6	2,225.1	2,346.6	2,895	2,949.7	2,610.2	2,151.6	1,934.8	1,817.2
FixedAssets_A Fixed Assets Ann. ⌄	-3.2%	-0.2%	1,435.7	1,466.9	1,517.5	1,580.5	1,572.8	1,446.7	1,414.3	1,133.3	1,132.9
TangibleAssets_A Tangible Assets Ann.	-2.6%	-1.4%	843.8	789.8	851.2	914	892.2	904.6	904.4	637.1	597.5
IntangibleAssets_A Intangible Assets Ann.	-2.6%	-2.7%	387.1	394.7	407.5	419.3	432.8	444.9	457.2	456.7	459.2
CapitalWorkInProgress_A Capital Work In Progress Ann.	-5%	18.5%	204.8	280.1	256.4	238.5	238.7	87.7	40.2	33.7	70.3
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-4.9%	-1.1%	1,467.9	1,496.5	1,556	1,704.1	1,709.8	1,552.2	1,476.3	1,320.4	1,208.6
NonCurrentInvestments_A Non Current Investments Ann.	-53.7%	-38.4%	1.6	1.7	14.3	16.1	18.1	18.1	18	149.1	18.5
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-				78.5	55.1	25.6
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-					1.6	1.7	1.5	0	0
OtherNonCurrentAssets_A Other Non Current Assets Ann.	1.8%	-12.6%	30.6	28	24.2	29	62.1	60.1	42.4	38	57.2
CA_A Total Current Assets Ann. ⌄	-12.1%	-5.2%	808.7	728.6	790.7	1,190.9	1,239.9	1,058	675.4	614.4	608.5
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	-6.7%	-1.9%	438.9	326.6	351.2	539.7	489.7	483.8	229.7	269	263.4
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-21.6%	-53.7%	4.2	4	8.5	8.7	47.1	198.4	56.6	73.8	46.9
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-	0	0	0.3	32.6	51.6	1.7	52.3	2.3	2
OtherCurrentAssets_A Other Current Assets Ann.	-2.6%	-9.6%	47.8	80.1	70.9	51.8	75.9	79.2	57	67.7	108.6
TA_A Total Assets Ann.	-7.7%	-2.7%	2,276.6	2,225.1	2,346.6	2,895	2,949.7	2,610.2	2,151.6	1,934.8	1,817.2
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	77.3%	15.2%	211.7	57.6	42.6	38	66.9	104.5	73.5	95.7
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	9.1	9.1	9.1	9.1	9.1	9.1
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-53.7%	-38.4%	1.6	1.7	14.3	16.1	17.7	18.1	18	149.1	18.5
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

2.3%

2Y CAGR

-1.5%

3Y CAGR

-7.7%

5Y CAGR

-2.7%

7Y CAGR

2.4%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

-5.4%

2Y CAGR

-15.3%

3Y CAGR

-6.8%

5Y CAGR

2.5%

7Y CAGR

5.1%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

14.5%

2Y CAGR

15.7%

3Y CAGR

-5.8%

5Y CAGR

-4.6%

7Y CAGR

5.5%

Total ShareHolders Funds Annual growth is higher than historical averages.

Solara Active Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Solara Active Pharma Mar-2026 Book Value Per Share is 282 Rs which is growth of 3.6% YoY.
POSITIVE
ROE Solara Active Pharma Mar-2026 ROE is -1% which is growth of 0.5% YoY.

Solara Active Pharma Sciences Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18
BVSH_A BVSH Ann.	-12.2%	-8.6%	282.1	272.4	260.4	417.5	424.2	443.4	370.5	334.3	312
ROA_A RoA Ann. %	-	-	-0.31%	-0.04%	-24.15%	-0.76%	-1.98%	8.46%	5.22%	3.20%	0.10%
ROE_A ROE Ann. %	-	-	-0.57%	-0.09%	-60.47%	-1.47%	-3.83%	13.87%	11.30%	7.19%	0.25%
ROCE_A ROCE Ann. %	38.6%	-16.8%	6.68%	8.83%	-17.37%	2.51%	-0.68%	16.73%	13.36%	11.77%	3.01%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	9.2%	-11.3%	14.06%	16.59%	-6.95%	10.81%	7.81%	25.58%	21.48%	17.03%	12.77%
PBITMargin_A EBIT Ann. Margin %	29.4%	-18.5%	6.78%	8.85%	-14.95%	3.13%	-1.01%	18.89%	14.40%	11.27%	6.27%
PBTMargin_A PBT Ann. Margin %	-	-	-0.52%	-0.08%	-37.88%	-3.10%	-7.22%	13.66%	8.51%	5.24%	1.45%
NETPCT_A NPM Ann. %	-	-	-0.52%	-0.08%	-43.98%	-1.53%	-4.61%	13.66%	8.51%	4.53%	0.37%
ASETTO_A Asset Turnover Ann. %	6.3%	-3%	0.6	0.6	0.5	0.5	0.5	0.7	0.7	-	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-6.5%	-8.5%	0.9	0.8	0.6	1.1	1.2	1.4	0.9	1	0.8
QuickRatio_A Quick Ratio Ann.	0%	-9.7%	0.6	0.4	0.4	0.6	0.6	1	0.5	0.7	0.6
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-					-0.3	0.1	0.2		-
EarningRetention_A Earning Retention Ann. %	-	-					118.40%	91.07%	86.08%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-					79.84%	94.01%	92.41%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-					79.84%	94.01%	92.41%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	4.8%	-14%	2,502.8	2,835.7	2,331.7	2,174.7	3,372	5,325.5	1,719.8	1,445.7
EVPerNetSales_A EV Per Net Sales Ann.	6.3%	-11.4%	1.8	2.2	1.8	1.5	2.7	3.3	1.3	1.1	-
PBV_A Price To Book Value Adjusted	16.9%	11.1%	2.73	2.89	2.75	1.71	1.69	1.61	1.93	2.14	2.29
EVPerEBITDA_A EV Per EBITDA Ann.	-2.2%	0.2%	13	13.3	-26	13.9	34	12.9	6.1	6.2	-
MarketCapPerSales_A Market Cap Per Sales Ann.	20.5%	-14.7%	1.4	1.6	1	0.8	1.9	3.1	0.9	0.8	-
RetentionRatios_A Retention Ratio Ann. %	-	-					118.40%	91.06%	86.07%
EYield_A Earnings Yield Ann.	-	-			-0.4	-0	-0	0	0.1	0.1
DEBT_CE_A Total Debt to Total Equity Ann.	-10.6%	10.8%	0.5	0.7	1.1	0.7	0.7	0.3	0.6	0.5	0.7

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Current Ratio Ann.

1Y CHG

12.5%

2Y CAGR

22.5%

3Y CAGR

-6.5%

5Y CAGR

-8.5%

7Y CAGR

-1.5%

Current Ratio Annual growth is higher than historical averages.

Solara Active Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Solara Active Pharma Mar-2026 Cash From Operating Activity is Rs 153 Cr which is growth of -28.2% YoY.
POSITIVE
Net Cash Flow Solara Active Pharma Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of 104.2% YoY.

Solara Active Pharma Sciences Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18
CFO_A Cash from Operating Act. Ann. ⌄	-0.7%	-0.2%	152.9	212.8	111	156.2	-241.8	154.4	244.1	174.9	49.6
PBT_A PBT Ann.	-	-	-7.2	-1.1	-488.3	-44.8	-91.7	221	112.5	71.7	7.6
INT_A Interest Ann.	1.5%	2.2%	94.2	114.8	106	90.1	75.3	84.5	77.9	82.4	25.1
TAX_A Tax Ann.	-	-			78.5	-22.6	-33.1			2
CFI_A Cash from Investing Act. Ann.	-	-	-50.1	-36.8	-4.7	-81.1	-243.1	-105.3	-358.8	-124.7	-85.5
CFA_A Cash from Financing Act. Ann.	-	-	-102.6	-180.5	-106.5	-112.8	333.6	92.5	94.9	-23	67.4
NCF_A Net Cash Flow Ann. ⌄	-	-73.1%	0.2	-4.5	-0.2	-37.7	-151.3	141.7	-19.8	27.3	31.5
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-56.5%	-41.6%	3.8	8.3	8.6	46.3	197.5	55.8	75.6	45.9
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-22.5%	-54.2%	4	3.8	8.3	8.6	46.3	197.5	55.8	73.1	45.9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-28.1%

2Y CAGR

17.4%

3Y CAGR

-0.7%

5Y CAGR

-0.2%

7Y CAGR

-1.9%

Cash from Operating Activity Annual is falling faster than historical averages.

Solara Active Pharma investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

69.40% Gain from 52W Low

Solara Active Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Solara Active Pharma - Forecaster

Forecaster Analyst Estimates for Solara Active Pharma share price target, revenues, EPS, net income and more